RDX5791
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RDX5791, covering 2016-06-10 to 2019-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C) [Phase 2]